Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmaceutical Poisoning: Treatment Strategies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 29, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Marta Lozano-Lanagrán1, Mercedes Robles, María Isabel Lucena
1Unit of Hepatology, Department of Digestive Diseases, Hospital Universitario Virgen de la Victoria, School of Medicine, Boulevard Louis Pasteur no. 32, Málaga, Spain.
No abstract available in PubMed .
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025